Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Nicholas Santiago
Here's Where I'll Buy Carmax By Nicholas Santiago - Dec 21, 2017

Used auto retailer CarMax (NYSE:KMX) took a hit Thursday when it reported lower earnings. Half way though Thrusday's U.S. market, the stock was down by 4.29% to $65.55 a share. KMX is now slightly...

Samuel Rae
Can PolarityTE Grow Skin From Scratch? By Samuel Rae - Dec 21, 2017

What if we can grow fully functional skin, hair follicles and all, with just a biopsy? It’s been done successfully in large animal studies already, and one biotech firm called PolarityTE Inc....

Samuel Rae
3 Drugs That Could Shake Up Diabetes Space In 2018 By Samuel Rae - Dec 21, 2017

2018 could be an incredible year for patients in the diabetes space. A number of fresh treatments have either picked up approval at the end of this year (and, in turn, are due to launch early next...

Al Brooks
Emini Traders Eye Government Shutdown By Al Brooks - Dec 21, 2017

Pre-Open Market AnalysisThe Emini sold off yesterday in a trend from the open bear trend. In addition, it traded below Friday’s high. It therefore closed the gap on the daily and weekly charts,...

Gregor Horvat
S&P 500 Looking At 2700 For A New High By Gregor Horvat - Dec 21, 2017

Good day traders!S&P 500 is trading within a five-wave bullish move, away from 2650 level, where corrective wave iv had ended. We need five-waves for a completed pattern and in our case final...

Edison
Reneuron Group: Biblical Aspirations   By Edison - Dec 21, 2017

Reneuron Group's (LON:RQE) interim results for the six months to 30 September 2017 showcased a crucial juncture in the company’s history. With the first of two US placebo-controlled, late-stage...

Zacks Investment Research
Value Stocks Breaking Out Ahead Of 2018 By Zacks Investment Research - Dec 21, 2017

(0:20) - 2017 Record Highs In The Stock Market: Was It A Perfect Year?(1:40) - Stocks Close To 52 Week Highs(4:00) - Tracey's Top Stock Picks(10:00) - Episode Roundup: Podcast@Zacks.comWelcome to...

Zacks Investment Research
5 Reasons Why 2018 Could Be Good For IPO ETFs By Zacks Investment Research - Dec 21, 2017

After a subdued 2016, the U.S. IPO market catapulted in 2017. The rise was credited to a surging stock market, improving economic fundamentals and increasing consumer sentiment that led to the appeal...

Edison
Kazia Therapeutics: GDC-0084 Phase Ii To Begin Shortly   By Edison - Dec 21, 2017

Novogen has changed its name to Kazia Therapeutics Ltd ADR (NASDAQ:KZIA) and undertaken a 10:1 share consolidation following shareholder approval in November. It has also out-licensed its preclinical...

Zacks Investment Research
Can IBM Make A Comeback In 2018 After An Unimpressive 2017? By Zacks Investment Research - Dec 21, 2017

The technology sector has been one of the best performing sectors this year so far. However, not all the companies have fared that well. International Business Machines Corp. (NYSE:IBM) is one of...

Continue with Apple
Continue with Google
or
Sign up with Email